Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 28 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 10272137

    Compositions and methods relating to myomaker-induced muscle cell fusion

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  2. US 10272084

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  3. US 10272099

    Tumor-selective combination therapy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  4. US 10265405

    Polymers for delivery of factor VIII and/or factor IX

    The Board of Regents of the University of Texas System · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  5. US 10265338

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  6. US 10267786

    Systems and methods for high-resolution imaging

    The Board of Regents of the University of Texas System · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  7. US 10258631

    Formulations of testosterone and methods of treatment therewith

    The Board of Regents of the University of Texas System · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  8. US 10253424

    Porous particles and methods of making thereof

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  9. US 10251909

    Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  10. US 10251398

    Improving shelf life and color profile of resin compositions with silver nanoparticles

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  11. US 10240130

    CDNA clone-launched platform for high-yield production of inactivated zika virus

    The Board of Regents of the University of Texas System · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  12. US 10238698

    Biomarkers and combination therapies using oncolytic virus and immunomodulation

    The Board of Regents of the University of Texas System · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  13. US 10238770

    Reparative cell isolation and delivery

    The Board of Regents of the University of Texas System · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  14. US 10231958

    Methods and compositions for enhancing chemotherapy

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  15. US 10233438

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  16. US 10231955

    Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  17. US 10221235

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  18. US 10220078

    Methods of using thrombin derivatives to treat medulloblastoma

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  19. US 10219492

    Compounds and methods for altering RSV replication rate

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  20. US 10214529

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  21. US 10208059

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  22. US 10207013

    Gadolinium-based contrast agents for sensitive detection of Zn2+ with MRI

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  23. US 10208012

    Compounds for treating inflammatory and hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  24. US 10201554

    Esters of 2-deoxy-monosacharides with anti proliferative activity

    The Board of Regents of the University of Texas System · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.